XML 50 R40.htm IDEA: XBRL DOCUMENT v3.25.3
Financial Instruments - Additional Information (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 03, 2025
USD ($)
Sep. 30, 2020
Dec. 31, 2025
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Jun. 30, 2022
$ / shares
Derivative [Line Items]                          
Trade and other receivables       $ 396,000,000   $ 396,000,000     $ 342,000,000        
Debt securities interest income           94,000,000     62,000,000        
Net loss on equity method investment       21,000,000 $ 28,000,000 68,000,000 $ 116,000,000            
Net gain (loss) on equity and other investments       (62,000,000) 512,000,000 (401,000,000) 63,000,000            
Unrealized loss on embedded derivative       29,000,000 0 29,000,000 0            
0.125% Convertible Senior Notes Due 2025 | Convertible Debt                          
Derivative [Line Items]                          
Conversion ratio   0.00069440                      
Conversion price (in dollars per share) | $ / shares                         $ 144.01
Forecast | 0.125% Convertible Senior Notes Due 2025 | Convertible Debt                          
Derivative [Line Items]                          
Loss on settlement of Notes     $ 123,000,000         $ 123,000,000          
Subsequent Event | 0.125% Convertible Senior Notes Due 2025 | Convertible Debt                          
Derivative [Line Items]                          
Settlement of Notes and embedded derivative $ 1,000,000,000.0                        
Klaviyo, Inc.                          
Derivative [Line Items]                          
Net gain (loss) on equity and other investments       (75,000,000) 59,000,000 (147,000,000) 36,000,000            
Equity Securities Without Readily Determinable Fair Value                          
Derivative [Line Items]                          
Equity and Other Investments       $ 974,000,000 $ 683,000,000 $ 974,000,000 $ 683,000,000   $ 717,000,000 $ 988,000,000 $ 683,000,000 $ 505,000,000  
Call Option | Klaviyo, Inc.                          
Derivative [Line Items]                          
Option to purchase series B common shares | shares           15,743,174              
Exercise price (in dollars per share) | $ / shares           $ 88.93              
Discount for Lack of Marketability | Klaviyo, Inc.                          
Derivative [Line Items]                          
Derivative asset, measurement input       0.21   0.21     0.29        
Fair value       $ 57,000,000   $ 57,000,000     $ 204,000,000        
Foreign Exchange Forward                          
Derivative [Line Items]                          
Foreign exchange forward contracts, notional value       708,000,000   708,000,000     454,000,000        
Level 3 | Fair Value, Nonrecurring                          
Derivative [Line Items]                          
Equity and Other Investments       824,000,000   824,000,000              
Level 2                          
Derivative [Line Items]                          
Fair value of embedded derivative       29,000,000   29,000,000              
Level 2 | Foreign Exchange Forward                          
Derivative [Line Items]                          
Fair value       2,000,000   2,000,000     0        
Accrued interest                          
Derivative [Line Items]                          
Trade and other receivables       $ 36,000,000   $ 36,000,000     $ 19,000,000